1. What Sanofi might buy with its Regeneron windfall — Gilead pens $2B Arcus pact for immuno-oncology targets — FDA approves BMS Opdivo + Yervoy combo for first-line on certain types of NSCLC — See more on our front page news Stay updated with the latest pharma-related coronavirus news on our new page
    Dismiss Notice
  2. Think you have witnessed fraud?Ask a Whistleblower Attorney -- a chance to discuss whistleblower-related legal issues with practicing whistleblower attorneys.
    Dismiss Notice

Just a hello

Discussion in 'Cafepharma Playground' started by Wonka, Nov 19, 2018 at 5:30 AM.

  1. Wonka

    Wonka Active Member

    Joined:
    Mar 3, 2006
    Messages:
    3,230
    Likes Received:
    13
    Hello
     
    Vagitarian likes this.